Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Sleep disorders and Alzheimer’s disease

Full Text:


Alzheimer’s disease (AD), one of the leading causes of dementia worldwide, is commonly accompanied by behavioral and psychopathological disorders. The earliest observed symptoms of AD include sleep disorders, the incidence of which varies from 25 to 60%. Sleep problems and sleep disorders can develop as one of the symptoms accompanying cognitive impairment, but can also be associated with an increased risk of cognitive decline and with a higher risk of dementia. Anti-dementia therapy is of great importance in preventing and treating sleep disorders in patients with AD. Akatinol memantine is one of the drugs with proven efficacy in such patients.

About the Author

A. N. Bogolepova
N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia
Russian Federation

Department of Neurology, Neurosurgery, and Medical Genetics, 

1, Ostrovityanov St., Moscow 117997 


1. Alzheimer’s Association. 2017 Alzheimer’s Disease Facts and Figures. Alzheimers Dement 2017;13:325-73

2. Hallikainen I, Hongisto K, Vä limä ki T, et al. The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study. J Alzheimers Dis. 2018;61(4):1367-1376. doi: 10.3233/JAD-170697.

3. Mander BA, Winer JR, Jagust WJ, Walker MP. Sleep: A novel mechanistic pathway, biomarker, and treatment target in the pathology of Alzheimer's disease? Trends Neurosci. 2016 Aug;39(8): 552-66. doi: 10.1016/j.tins.2016.05.002. Epub 2016 Jun 17.

4. Tractenberg RE, Singer CM, Kaye JA. Symptoms of sleep disturbance in persons with Alzheimer's disease and normal elderly. J Sleep Res. 2005 Jun;14(2):177-85. doi: 10.1111/j. 1365-2869.2005.00445.x].

5. Urrestarazu E, Iriarte J. Clinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategies. Nat Sci Sleep. 2016 Jan 14;8:21-33. doi: 10.2147/NSS.S76706. eCollection 2016.

6. Hart DJ, Craig D, Compton SA, et al. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer’s disease. Int J Geriatr Psychiatry. 2003 Nov;18(11):1037-42. doi: 10.1002/gps.1013

7. Garcia-Alberca JM, Lara JP, Cruz B, et al. Sleep disturbances in Alzheimer's disease are associated with neuropsychiatric symptoms and antidementia treatment. J Nerv Ment Dis. 2013 Mar;201(3):251-7. doi: 10.1097/NMD. 0b013e3182848d04.

8. DeOliveira FF, Bertolucci PH, Chen ES, Smith MA. Assessment of sleep satisfaction in patients with dementia due to Alzheimer's disease. J Clin Neurosci. 2014 Dec;21(12):2112-7. doi: 10.1016/j.jocn.2014.05.041. Epub 2014 Sep 4.

9. Born J, Wilhelm I. System consolidation of memory during sleep. Psychol Res. 2012 Mar; 76(2):192-203. doi: 10.1007/s00426-011-0335-6. Epub 2011 May 4.

10. Okamura T, Ura C, Miyamae F, et al. Excessive daytime sleepiness is related to subjective memory impairment in late life: a crosssectional community-based study. Psychogeriatrics. 2016 May;16(3):196-201. doi: 10.1111/psyg.12139. Epub 2015 Jul 16.

11. Burke SL, Maramaldi P, Cadet T, Kukull W. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia. Int Psychogeriatr. 2016 Sep;28(9):1409-24. doi: 10.1017/S1041610216000405. Epub 2016 Mar 29.

12. Xie L, Kang H, Xu Q, et al. Sleep Drives Metabolite Clearance from the Adult Brain. Science. 2013 Oct 18;342(6156):373-7. doi: 10.1126/science.1241224.

13. Luojus MK, Lehto SM, Tolmunen T, et al. Self-reported sleep disturbance and incidence of dementia in ageing men. J Epidemiol Community Health. 2017 Apr;71(4):329-335. doi: 10.1136/ jech-2016-207764. Epub 2016 Oct 18.

14. Chen JC, Espeland MA, Brunner RL, et al. Sleep duration, cognitive decline, and dementia risk in older women. Alzheimers Dement. 2016 Jan;12(1):21-33. doi: 10.1016/j.jalz.2015.03.004. Epub 2015 Jun 15.

15. Pase MP, Himali JJ, Grima NA, et al. Sleep architecture and the risk of incident dementia in the community. Neurology. 2017 Sep 19;89(12): 1244-1250. doi: 10.1212/WNL.0000000000004373. Epub 2017 Aug 23.

16. Shi L, Chen SJ, Ma MY, et al. Sleep disturbance increase the risk of dementia: A systematic review and meta-analysis. Sleep Med Rev. 2017 Jul 6. pii: S1087-0792(17)30011-4. doi: 10.1016/ j.smrv.2017.06.010. [Epub ahead of print]

17. Bubu OM, Brannick M, Mortimer J, et al. Sleep, Cognitive impairment, and Alzheimer's disease: A Systematic Review and MetaAnalysis. Sleep. 2017 Jan 1;40(1). doi: 10.1093/ sleep/zsw032.

18. Mander BA, Marks SM, Vogel JW, et al. β-amyloid disrupts human NREM slow waves and related hippocampus-dependent memory consolidation. Nat Neurosci. 2015 Jul;18(7):1051-7. doi: 10.1038/nn.4035. Epub 2015 Jun 1.

19. Kang DW, Lee ChU, Lim HK. Role of Sleep Disturbance in the Trajectory of Alzheimer’s Disease. Clin Psychopharmacol Neurosci. 2017 May 31;15(2):89-99. doi: 10.9758/cpn.2017.15.2.89.

20. Rothman SM, Mattson MP. Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases. Neuromolecular Med. 2012 Sep; 14(3):194-204. doi: 10.1007/s12017-012-8181-2. Epub 2012 May 3.

21. Cedernaes J, Osorio RS, Varga AW, et al. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer’s disease. Sleep Med Rev. 2017 Feb; 31:102-111. doi: 10.1016/j.smrv.2016.02.002. Epub 2016 Feb 11.

22. Lucey BP, Bateman RJ. Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis. Neurobiol Aging. 2014 Sep;35 Suppl 2:S29-34. doi: 10.1016/j.neurobiolaging.2014.03.035. Epub 2014 May 15.

23. Spira AP, Gamaldo AA, An Y, et al. Selfreported sleep and -amyloid deposition in community-dwelling older adults. JAMA Neurol. 2013 Dec;70(12):1537-43. doi: 10.1001/jamaneurol.2013.4258

24. Rothman SM, Herdener N, Frankola KA, et al. Chronic mild sleep restriction accentuates contextual memory impairments, and accumulations of cortical Abeta and pTau in a mouse model of Alzheimer’s disease. Brain Res. 2013 Sep 5;1529:200-8. doi: 10.1016/j.brainres.2013. 07.010. Epub 2013 Jul 13.

25. DiMeco A, Joshi YB, Pratico D. Sleep deprivation impairs memory, tau metabolism, and synaptic integrity of a mouse model of Alzheimer's disease with plaques and tangles. Neurobiol Aging. 2014 Aug;35(8):1813-20. doi: 10.1016/j. neurobiolaging.2014.02.011. Epub 2014 Feb 15.

26. Fronczek R, van Geest S, Fr?lich M, et al. Hypocretin (orexin) loss in Alzheimer’s disease. Neurobiol Aging. 2012 Aug;33(8):1642-50. doi: 10.1016/j.neurobiolaging.2011.03.014. Epub 2011 May 5.4

27. Urrestarazu E, Iriarte J. Clinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategies. Nat Sci Sleep. 2016 Jan 14;8:21-33. doi: 10.2147/NSS. S76706. eCollection 2016

28. Tarragon E, Lopez D, Estrada C, et al. Memantine prevents reference and working memory impairment caused by sleep deprivation in both young and aged Octodondegus. Neuropharmacology. 2014 Oct;85:206-14. doi: 10.1016/j.neuropharm.2014.05.023. Epub 2014 May 27.

29. Ito K, Tatebe T, Suzuki K, et al. Memantine reduces the production of amyloid-β peptides through modulation of amyloid precursor protein trafficking. Eur J Pharmacol. 2017 Mar 5;798:16-25. doi: 10.1016/j.ejphar. 2017.02.001. Epub 2017 Feb 4.

30. Kishi T, Matsunaga Sh, Iwata N. The effects of memantine on behavioral disturbances in patients with Alzheimer’s disease: a metaanalysis. Neuropsychiatr Dis Treat. 2017 Jul 20;13:1909-1928. doi: 10.2147/NDT.S142839. eCollection 2017.

31. Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer’s disease: a systematic review and meta-analysis. PLoS One. 2015 Apr 10;10(4):e0123289. doi: 10.1371/journal. pone.0123289. eCollection 2015.

32. Ishikawa I, Shinno H, Ando N, et al. The effect of memantine on sleep architecture and psychiatric symptoms in patients with Alzheimer's disease. Acta Neuropsychiatr. 2016 Jun;28(3):157-64. doi: 10.1017/neu.2015.61


For citations:

Bogolepova A.N. Sleep disorders and Alzheimer’s disease. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(1):74-77. (In Russ.)

Views: 639

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)